Benchmark Reiterates Speculative Buy on HeartBeam, Maintains $8 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bill Sutherland has reiterated a Speculative Buy rating on HeartBeam (NASDAQ:BEAT) and maintained an $8 price target.
March 25, 2024 | 4:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst reiterates Speculative Buy on HeartBeam with an $8 price target.
The reiteration of a Speculative Buy rating and the maintenance of an $8 price target by a Benchmark analyst could positively influence investor sentiment towards HeartBeam. This endorsement may lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100